Actively Recruiting
Differential Diagnosis of Cognitive Disorders of Psychiatric or Neurodegenerative Origin
Led by Central Hospital, Nancy, France · Updated on 2025-02-03
20
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the research is to analyze whether 18F-FDG PET helps in the diagnosis and therefore in the management of the patient.
CONDITIONS
Official Title
Differential Diagnosis of Cognitive Disorders of Psychiatric or Neurodegenerative Origin
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with cognitive impairment
- Positron emission tomography with flurodeoxyglucose labeled with fluorine 18 carried out in the course of care
You will not qualify if you...
- Patients objecting to the collection of their data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nancy's hospital
Vandœuvre-lès-Nancy, France, 54511
Actively Recruiting
Research Team
A
Antoine VERGER, MD, PhD
CONTACT
V
VERONIQUE ROCH, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here